Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor
Pharmaceuticals · 22.06.2024 · 17 (7) · 821
DOI: 10.3390/ph17070821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 22.06.2024. Verfasst von Nqobile Monate Mkolo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council (SAMRC) through its Division of Research Capacity Development, South African Medical Research Council (SAMRC), Division of Research Capacity Development.
Abstract (Originalsprache)
The expected progress in SARS-CoV-2 vaccinations, as anticipated in 2020 and 2021, has fallen short, exacerbating global disparities due to a lack of universally recognized “safe and effective” vaccines. This study focuses on extracts of South African medicinal plants, Artemisia annua and Artemisia afra, to identify metabolomic bioactive compounds inhibiting the binding of the SARS-CoV-2 spike protein to ACE2 receptors. The extracts were monitored for cytotoxicity using a resazurin cell viability assay and xCELLigence real-time cell analyzer. Chemical profiling was performed using UPLC-MS/MS, orthogonal projection to latent structures (OPLS), and evaluated using principle component analysis (PCA) models. Identified bioactive compounds were subjected to in vitro SARS-CoV-2 enzyme inhibition assay using standard methods and docked into the spike (S) glycoprotein of SARS-CoV-2 using Schrodinger® suite followed by molecular dynamics simulation studies. Cell viability assays revealed non-toxic effects of extracts on HEK293T cells at lower concentrations. Chemical profiling identified 81 bioactive compounds, with compounds like 6″-O-acetylglycitin, 25-hydroxyvitamin D3-26,23-lactone, and sesaminol glucoside showing promising binding affinity. Molecular dynamics simulations suggested less stable binding, but in vitro studies demonstrated the ability of these compounds to interfere with SARS-CoV-2 spike protein’s binding to the human ACE2 receptor. Sesaminol glucoside emerged as the most effective inhibitor against this interaction. This study emphasizes the importance of multiplatform metabolite profiling and chemometrics to understand plant extract composition. This finding is of immense significance in terms of unravelling metabolomics bioactive compounds inhibiting the binding of the SARS-CoV-2 spike protein to ACE2 receptors and holds promise for phytotherapeutics against SARS-CoV-2.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
- Department of Biotechnology, Rhodes University, Makhanda 6140, South Africa.
- Department of Pharmacy, University of Tadulako, Palu 94118, Indonesia.
ORCID-Profile: Rose Kadye, Oyinlola Oluwunmi Olaokun, Earl Prinsloo
Förderung
- South African Medical Research Council (SAMRC) through its Division of Research Capacity Development
- South African Medical Research Council (SAMRC)
- Division of Research Capacity Development
Zitieren
APA
Mkolo, N. M., Naidoo, C. M., Kadye, R., Obi, C. L., Iweriebor, B. C., Olaokun, O. O., Prinsloo, E., & Zubair, M. S. (2024). Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor. Pharmaceuticals, 17(7), 821. https://doi.org/10.3390/ph17070821
Vancouver
Mkolo NM, Naidoo CM, Kadye R, Obi CL, Iweriebor BC, Olaokun OO, et al. Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor. Pharmaceuticals. 2024;17(7):821. doi:10.3390/ph17070821
BibTeX
@article{Mkolo2024,
author = {Mkolo, Nqobile Monate and Naidoo, Clarissa Marcelle and Kadye, Rose and Obi, Chikwelu Lawrence and Iweriebor, Benson Chucks and Olaokun, Oyinlola Oluwunmi and Prinsloo, Earl and Zubair, Muhammad Sulaiman},
title = {Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {7},
pages = {821},
doi = {10.3390/ph17070821}
}
EUVIMED